Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins

Tae Woo Kim, Chien Fu Hung, Morris Ling, Jeremy Juang, Liangmei He, J. Marie Hardwick, Sharad Kumar, T. C. Wu

Research output: Contribution to journalArticle

162 Citations (Scopus)

Abstract

Intradermal vaccination by gene gun efficiently delivers DNA vaccines into DCs of the skin, resulting in the activation and priming of antigen-specific T cells in vivo. DCs, however, have a limited life span, hindering their long-term ability to prime antigen-specific T cells. We reason that a strategy that prolongs the survival of DNA-transduced DCs will enhance priming of antigen-specific T cells and DNA vaccine potency. Here we show that codelivery of DNA encoding inhibitors of apoptosis (BCL-xL, BCL-2, XIAP, dominant negative caspase-9, or dominant negative caspase-8) with DNA encoding model antigens prolongs the survival of transduced DCs. More importantly, vaccinated mice exhibited significant enhancement in antigen-specific CD8+ T cell immune responses, resulting in a potent antitumor effect against antigen-expressing tumors. Among these antiapoptotic factors, BCL-xL demonstrated the greatest enhancement in antigen-specific immune responses and anti-tumor effects. Thus, coadministration of DNA vaccines with DNA encoding antiapoptotic proteins represents an innovative approach to enhance DNA vaccine potency.

Original languageEnglish
Pages (from-to)109-117
Number of pages9
JournalJournal of Clinical Investigation
Volume112
Issue number1
DOIs
Publication statusPublished - 2003 Jul 1
Externally publishedYes

Fingerprint

Vaccine Potency
DNA Vaccines
T-Lymphocytes
Antigens
DNA
Proteins
CD8 Antigens
Caspase 9
Caspase 8
Histocompatibility Antigens Class II
Firearms
Neoplasm Antigens
Vaccination
Apoptosis
Skin
Genes
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins. / Kim, Tae Woo; Hung, Chien Fu; Ling, Morris; Juang, Jeremy; He, Liangmei; Hardwick, J. Marie; Kumar, Sharad; Wu, T. C.

In: Journal of Clinical Investigation, Vol. 112, No. 1, 01.07.2003, p. 109-117.

Research output: Contribution to journalArticle

Kim, TW, Hung, CF, Ling, M, Juang, J, He, L, Hardwick, JM, Kumar, S & Wu, TC 2003, 'Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins', Journal of Clinical Investigation, vol. 112, no. 1, pp. 109-117. https://doi.org/10.1172/JCI200317293
Kim, Tae Woo ; Hung, Chien Fu ; Ling, Morris ; Juang, Jeremy ; He, Liangmei ; Hardwick, J. Marie ; Kumar, Sharad ; Wu, T. C. / Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins. In: Journal of Clinical Investigation. 2003 ; Vol. 112, No. 1. pp. 109-117.
@article{856b635732ec4f7cb1733bbcfbe0ec3f,
title = "Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins",
abstract = "Intradermal vaccination by gene gun efficiently delivers DNA vaccines into DCs of the skin, resulting in the activation and priming of antigen-specific T cells in vivo. DCs, however, have a limited life span, hindering their long-term ability to prime antigen-specific T cells. We reason that a strategy that prolongs the survival of DNA-transduced DCs will enhance priming of antigen-specific T cells and DNA vaccine potency. Here we show that codelivery of DNA encoding inhibitors of apoptosis (BCL-xL, BCL-2, XIAP, dominant negative caspase-9, or dominant negative caspase-8) with DNA encoding model antigens prolongs the survival of transduced DCs. More importantly, vaccinated mice exhibited significant enhancement in antigen-specific CD8+ T cell immune responses, resulting in a potent antitumor effect against antigen-expressing tumors. Among these antiapoptotic factors, BCL-xL demonstrated the greatest enhancement in antigen-specific immune responses and anti-tumor effects. Thus, coadministration of DNA vaccines with DNA encoding antiapoptotic proteins represents an innovative approach to enhance DNA vaccine potency.",
author = "Kim, {Tae Woo} and Hung, {Chien Fu} and Morris Ling and Jeremy Juang and Liangmei He and Hardwick, {J. Marie} and Sharad Kumar and Wu, {T. C.}",
year = "2003",
month = "7",
day = "1",
doi = "10.1172/JCI200317293",
language = "English",
volume = "112",
pages = "109--117",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins

AU - Kim, Tae Woo

AU - Hung, Chien Fu

AU - Ling, Morris

AU - Juang, Jeremy

AU - He, Liangmei

AU - Hardwick, J. Marie

AU - Kumar, Sharad

AU - Wu, T. C.

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Intradermal vaccination by gene gun efficiently delivers DNA vaccines into DCs of the skin, resulting in the activation and priming of antigen-specific T cells in vivo. DCs, however, have a limited life span, hindering their long-term ability to prime antigen-specific T cells. We reason that a strategy that prolongs the survival of DNA-transduced DCs will enhance priming of antigen-specific T cells and DNA vaccine potency. Here we show that codelivery of DNA encoding inhibitors of apoptosis (BCL-xL, BCL-2, XIAP, dominant negative caspase-9, or dominant negative caspase-8) with DNA encoding model antigens prolongs the survival of transduced DCs. More importantly, vaccinated mice exhibited significant enhancement in antigen-specific CD8+ T cell immune responses, resulting in a potent antitumor effect against antigen-expressing tumors. Among these antiapoptotic factors, BCL-xL demonstrated the greatest enhancement in antigen-specific immune responses and anti-tumor effects. Thus, coadministration of DNA vaccines with DNA encoding antiapoptotic proteins represents an innovative approach to enhance DNA vaccine potency.

AB - Intradermal vaccination by gene gun efficiently delivers DNA vaccines into DCs of the skin, resulting in the activation and priming of antigen-specific T cells in vivo. DCs, however, have a limited life span, hindering their long-term ability to prime antigen-specific T cells. We reason that a strategy that prolongs the survival of DNA-transduced DCs will enhance priming of antigen-specific T cells and DNA vaccine potency. Here we show that codelivery of DNA encoding inhibitors of apoptosis (BCL-xL, BCL-2, XIAP, dominant negative caspase-9, or dominant negative caspase-8) with DNA encoding model antigens prolongs the survival of transduced DCs. More importantly, vaccinated mice exhibited significant enhancement in antigen-specific CD8+ T cell immune responses, resulting in a potent antitumor effect against antigen-expressing tumors. Among these antiapoptotic factors, BCL-xL demonstrated the greatest enhancement in antigen-specific immune responses and anti-tumor effects. Thus, coadministration of DNA vaccines with DNA encoding antiapoptotic proteins represents an innovative approach to enhance DNA vaccine potency.

UR - http://www.scopus.com/inward/record.url?scp=0042964824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042964824&partnerID=8YFLogxK

U2 - 10.1172/JCI200317293

DO - 10.1172/JCI200317293

M3 - Article

C2 - 12840065

AN - SCOPUS:0042964824

VL - 112

SP - 109

EP - 117

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -